Mild Cognitive Impairment (MCI) clinical trials in Minnesota
13 active Mild Cognitive Impairment (MCI) trials with a site in Minnesota. Describe your situation to see which ones look like a fit.
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
- An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
- Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
- TMS Pilot in Early AD II
- MR Elastography of Cognitive Impairment
- Alzheimer's Disease Neuroimaging Initiative 4
- Tau PET Outcomes With Anti-amyloid Immunotherapies
- MIBG in Aging and Neurologic Disorders
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
- Imaging of Brain Amyloid Plaques in the Aging Population
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.